{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:36:26Z","timestamp":1767861386808,"version":"3.49.0"},"reference-count":16,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FVVO"],"DOI":"10.52054\/fvvo.2025.11","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T07:41:31Z","timestamp":1747986091000},"source":"Crossref","is-referenced-by-count":0,"title":["A total endoscopic levonorgestrel-releasing intrauterine system (LNG-IUS) placement: a novel approach for obese patients with early-stage endometrial cancer"],"prefix":"10.52054","author":[{"given":"Ursula","family":"Catena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Bonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"La Fera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Dinoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fanfani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1200\/JCO.2016.69.4638","article-title":"Addressing the role of obesity in endometrial cancer risk, prevention, and treatment","volume":"34","author":"Onstad","year":"2016","unstructured":"2. Onstad MA, Schmandt RE, Lu KH. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol. 2016;34:4225-30.","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","unstructured":"3. Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31:12-39.","journal-title":"Int J Gynecol Cancer"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ygyno.2015.09.020","article-title":"The impact of BMI on surgical complications and outcomes in endometrial cancer surgery--an institutional study and systematic review of the literature","volume":"139","author":"Bouwman","year":"2015","unstructured":"4. Bouwman F, Smits A, Lopes A, Das N, Pollard A, Massuger L, et al. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery--an institutional study and systematic review of the literature. Gynecol Oncol. 2015;139:369-76.","journal-title":"Gynecol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.brachy.2015.06.002","article-title":"Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer","volume":"14","author":"Schwarz","year":"2015","unstructured":"5. Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, et al. Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy. 2015;14:587-99.","journal-title":"Brachytherapy"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Boyd O, Jackson N. How is risk defined in high-risk surgical patient management? Crit Care. 2005;9:390-6.","DOI":"10.1186\/cc3057"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/ALN.0000000000001541","article-title":"Adding examples to the ASA-physical status classification improves correct assignment to patients","volume":"126","author":"Hurwitz","year":"2017","unstructured":"7. Hurwitz EE, Simon M, Vinta SR, Zehm CF, Shabot SM, Minhajuddin A, et al. Adding examples to the ASA-physical status classification improves correct assignment to patients. Anesthesiology. 2017;126:614-22.","journal-title":"Anesthesiology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.52054\/FVVO.13.4.037","article-title":"International Consensus Statement for recommended terminology describing hysteroscopic procedures","volume":"13","author":"Carugno","year":"2021","unstructured":"8. Carugno J, Grimbizis G, Franchini M, Alonso L, Bradley L, Campo R, et al. International Consensus Statement for recommended terminology describing hysteroscopic procedures. Facts Views Vis Obgyn. 2021;13:287-94.","journal-title":"Facts Views Vis Obgyn"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1097\/IGC.0b013e3182a26edb","article-title":"Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era","volume":"23","author":"Creutzberg","year":"2013","unstructured":"9. Creutzberg CL, Kitchener HC, Birrer MJ, Landoni F, Lu KH, Powell M, et al. Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era. Int J Gynecol Cancer. 2013;23:1528-34.","journal-title":"Int J Gynecol Cancer"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"100914","DOI":"10.1016\/j.gore.2021.100914","article-title":"Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: a qualitative study","volume":"39","author":"O'Hara","year":"2021","unstructured":"10. O'Hara M, Janda M, McCarthy AL, Nicklin J, Walker G, Obermair A. Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: a qualitative study. Gynecol Oncol Rep. 2021;39:100914.","journal-title":"Gynecol Oncol Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/ijgc-2022-004047","article-title":"ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma","volume":"33","author":"Rodolakis","year":"2023","unstructured":"11. Rodolakis A, Scambia G, Planchamp F, Acien M, Di Spiezio Sardo A, Farrugia M, et al. ESGO\/ESHRE\/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Int J Gynecol Cancer. 2023;33:208-22.","journal-title":"Int J Gynecol Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cct.2014.06.014","article-title":"Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device \u00b1 metformin \u00b1 weight loss in endometrial cancer (feMME) trial","volume":"39","author":"Hawkes","year":"2014","unstructured":"12. Hawkes AL, Quinn M, Gebski V, Armes J, Brennan D, Janda M, et al. Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device \u00b1 metformin \u00b1 weight loss in endometrial cancer (feMME) trial. Contemp Clin Trials. 2014;39:14-21.","journal-title":"Contemp Clin Trials"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Janda M, Robledo KP, Gebski V, Armes JE, Alizart M, Cummings M, et al. Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: results of a randomized clinical trial. Gynecol Oncol. 2021;161:143-51. Erratum in: Gynecol Oncol. 2021;162:526.","DOI":"10.1016\/S0090-8258(21)00726-5"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Kim MK, Seong SJ, Kang SB, Bae DS, Kim JW, Nam JH, et al. Six months response rate of combined oral medroxyprogesterone\/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study. J Gynecol Oncol. 2019;30:e47.","DOI":"10.3802\/jgo.2019.30.e47"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","unstructured":"15. Minig L, Franchi D, Boveri S, Casadio C, Bocciolone L, Sideri M. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann Oncol. 2011;22:643-9.","journal-title":"Ann Oncol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Westin SN, Fellman B, Sun CC, Broaddus RR, Woodall ML, Pal N, et al. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer. Am J Obstet Gynecol. 2021;224:191.e1-191.e15.","DOI":"10.1016\/j.ajog.2020.08.032"}],"container-title":["Facts Views and Vision in ObGyn"],"original-title":[],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T08:07:23Z","timestamp":1753430843000},"score":1,"resource":{"primary":{"URL":"https:\/\/fvvo.eu\/articles\/a-total-endoscopic-levonorgestrel-releasing-intrauterine-system-lng-ius-placement-a-novel-approach-for-obese-patients-with-early-stage-endometrial-cancer\/doi\/FVVO.2025.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":16,"URL":"https:\/\/doi.org\/10.52054\/fvvo.2025.11","relation":{},"ISSN":["2032-0418","2684-4230"],"issn-type":[{"value":"2032-0418","type":"print"},{"value":"2684-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}